Three-/four-repeat-dependent aggregation profile of tau microtubule-binding domain clarified by dynamic light

Etsuko Sugino1, Chisato Nishiura, Katsuhiko Minoura

  • 1Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, Japan.

Insights

Understanding tau microtubule-binding domain (MBD) self-assembly is key to inhibiting filament formation. Dynamic Light Scattering reveals distinct aggregation pathways for 3RMBD and 4RMBD, identifying critical dimer and monomer units.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Structural Biology

Background:

  • Tau protein self-assembly into filaments is central to neurodegenerative diseases.
  • The microtubule-binding domain (MBD) is the core region responsible for tau filament formation.
  • Existing methods like fluorescence spectroscopy indirectly assess aggregation without revealing dynamic changes.

Purpose of the Study:

  • To elucidate the self-assembly mechanism of tau MBD.
  • To identify the specific structural units initiating MBD aggregation.
  • To differentiate the aggregation pathways of different MBD variants.

Main Methods:

  • Dynamic Light Scattering (DLS) was employed to directly analyze the aggregation of 3RMBD, 4RMBD, and their component repeats.
  • DLS allowed for the direct observation of time-dependent changes in aggregation size and volume.
  • Comparison with conventional fluorescence spectroscopy was performed.

Main Results:

  • DLS directly demonstrated that the aggregation initiating unit for 3RMBD is an intermolecular R3-R3 disulfide-bonded dimer.
  • DLS identified the aggregation initiating unit for 4RMBD as an intramolecular R2-R3 disulfide-bonded monomer.
  • Distinct aggregation processes under physiological conditions were revealed for 3RMBD and 4RMBD, differing from previous findings.

Conclusions:

  • The study provides a repeat-number-dependent aggregation model for MBD.
  • Understanding the role of each repeat in aggregation is crucial for therapeutic strategies.
  • These findings offer insights for developing methods to prevent tau filament (PHF) formation.